Red Star Macalline Group Corporat.../ CNE100002RX7 /
2024-05-31 9:00:00 AM | Chg. -0.03 | Volume | Bid2024-05-31 | Ask9:00:03 AM | High | Low |
---|---|---|---|---|---|---|
3.08CNY | -0.96% | 11.93 mill. Turnover: 36.95 mill. |
3.08Bid Size: 289,200 | 3.09Ask Size: 119,700 | 3.13 | 3.07 |
GlobeNewswire
2:38 AM
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
2:00 AM
HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire
1:00 AM
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
12:43 AM
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
GlobeNewswire
06-02
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
06-02
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
06-02
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering